Bilirubin Fractionation: Nursing Guide
Bilirubin fractionation separates total bilirubin into direct (conjugated) and indirect (unconjugated) components to clarify jaundice patterns. Nurses support safe testing by confirming liver-panel orders, protecting specimens from light, correlating fractions with urine and stool color, trending with ALT, ALP, and GGT, and escalating when conjugated hyperbilirubinemia pairs with fever, pain, or hemodynamic changes.
Contents
Quick Facts
Key Takeaway
Direct (conjugated) bilirubin elevation suggests cholestasis or obstruction; indirect (unconjugated) elevation suggests hemolysis or impaired conjugation. Urine bilirubin is positive only with conjugated hyperbilirubinemia — indirect bilirubin does not appear in urine.
Specimen & Collection Details
Nurse quick-reference for collection prep that affects result quality.
Serum (gold-top) per many laboratory protocols
Verify local tube, additive, and serum vs plasma requirements; protect from light per laboratory policy
Serum or plasma (venous blood)
Typically collected as part of a liver function panel — volume per institutional phlebotomy protocol
Often with morning laboratory draw when fasting panel is ordered; repeat timing per prescriber for acute jaundice or cholestasis monitoring
May be required when ordered with fasting CMP or lipid panel — follow ordering clinician and laboratory instructions
Label promptly; protect from light and hemolysis; transport per laboratory policy
Varies by site — many hospital chemistry results within hours; outpatient may be next day
Clinical chemistry / liver function panel
What is Bilirubin Fractionation?
Bilirubin Fractionation is a blood test that measures bilirubin — a yellow pigment formed when red blood cells break down — and often reports total bilirubin with direct (conjugated) and indirect (unconjugated) components. Direct bilirubin has been processed by the liver for excretion; indirect bilirubin has not. Many laboratories calculate indirect bilirubin as total minus direct. The test is commonly ordered with other liver function tests during jaundice evaluation.
Overview
Nurses encounter bilirubin fractionation in outpatient jaundice workups, preoperative labs, hepatitis surveillance, biliary obstruction evaluation, and hemolysis assessment. bilirubin testing helps find the cause of jaundice and monitor liver disease. Fractionation helps the care team determine whether hyperbilirubinemia is predominantly conjugated (cholestatic/obstructive pattern) or unconjugated (hemolysis or impaired conjugation).
standard clinical references guidance on unconjugated hyperbilirubinemia and liver function testing emphasizes that bilirubin must be interpreted with the clinical picture, urine findings, stool color, and companion enzymes — not as isolated numbers. ACG and AASLD abnormal liver chemistries guidance supports evaluating cholestatic patterns with bilirubin and alkaline phosphatase when jaundice or pruritus is present.
Before collection, verify the correct panel (total and direct bilirubin or full LFT), fasting requirements, and symptoms including scleral icterus, pruritus, RUQ pain, dark urine, and pale stool. After results return, compare direct and indirect fractions to prior values and to ALT, ALP, and GGT; note whether urine dipstick bilirubin is positive (conjugated pattern). Escalate fever, hypotension, worsening pain, or rapidly rising direct bilirubin according to facility policy.
Jaundice Pattern and Bilirubin Escalation Safety
Bilirubin fractionation is widely ordered, which can make nurses treat total bilirubin as a single number. A rising direct (conjugated) fraction with positive urine bilirubin may signal cholestasis or obstruction even when indirect bilirubin looks less dramatic. Always trend direct and indirect fractions with urine and stool color, companion liver enzymes, and symptoms.
- Rapidly rising direct bilirubin with fever, RUQ pain, jaundice, or hypotension — possible cholangitis or biliary obstruction
- Positive urine bilirubin with pale stool and cholestatic enzymes — conjugated hyperbilirubinemia needing urgent workup
- Marked indirect bilirubin rise with hemolysis symptoms or falling hemoglobin
- Dismissing jaundice because total bilirubin was “only mildly” elevated on a prior visit
Document: total, direct, and indirect values with reference intervals; urine bilirubin; stool color; companion ALT/ALP/GGT; prescriber notification; and patient teaching on red flags.
What Bilirubin Fractionation Can and Cannot Tell You
This test can help identify:
- Whether hyperbilirubinemia is predominantly conjugated (direct) or unconjugated (indirect)
- Patterns suggesting cholestasis/obstruction vs hemolysis or impaired conjugation (standard clinical references; standard clinical references)
- Trends during hepatitis, biliary disease, hemolysis, or medication monitoring
- Need for imaging, hematology workup, or hepatology referral when paired with clinical findings
This test cannot:
- Diagnose gallstones, obstruction site, or specific hepatitis etiology by itself
- Replace abdominal ultrasound, MRCP, or ERCP when obstruction is suspected
- Rule out jaundice when total bilirubin is normal but direct fraction is trending up
- Quantify severity of liver failure without synthetic function markers and clinical assessment
Pre-draw Checks for Bilirubin Fractionation Panels
Verify
Clarify before proceeding when:
- Order is unclear (total bilirubin only vs fractionation vs full LFT panel)
- Fasting status conflicts with MAR or patient report
- Visible jaundice with hemodynamic instability before routine outpatient draw — assess acuity first
- Prior hemolyzed or light-exposed specimen — confirm repeat collection technique
- Critical bilirubin notification pending without prescriber acknowledgment
- Urine bilirubin positive at bedside but no fractionation on current order — clarify panel
- Result conflicts with obvious cholestasis signs (pale stool, pruritus) and “normal” total bilirubin
Direct vs Indirect Bilirubin in Jaundice Workups
Integrate direct and indirect fractions with ALT, ALP, GGT, INR/albumin when available, urine bilirubin, stool color, hemolysis markers, medicines, and trends. Direct elevation with ALP/GGT rise supports cholestasis; indirect predominance with hemolysis signs prompts hematology correlation unconjugated hyperbilirubinemia guidance.
| Pattern | Typical fraction clue | Nursing focus |
|---|---|---|
| Cholestasis / obstruction | Direct bilirubin elevated; urine bilirubin positive; pale stool | Notify prescriber; support imaging; monitor fever and pain |
| Hemolysis | Indirect bilirubin elevated; urine bilirubin negative; urobilinogen may rise | Coordinate CBC and hemolysis workup as ordered |
| Hepatocellular injury | ALT/AST elevated; bilirubin may rise with mixed pattern | Trend full panel; monitor encephalopathy and coagulopathy signs |
| Impaired conjugation (e.g., Gilbert) | Mild indirect elevation; well patient; intermittent pattern | Document baseline; avoid unnecessary alarm when clinically stable |
Reference ranges and critical values may vary by laboratory, institution, analyzer, age, sex, and clinical context. Always interpret results using the reporting laboratory’s reference range and local escalation policy.
Urine Color, Stool Color, and Fraction Traps at the Bedside
| Bedside point | Nursing note |
|---|---|
| Urine bilirubin trap | Positive urine bilirubin means conjugated hyperbilirubinemia — indirect bilirubin does not appear in urine |
| Stool color | Pale or clay-colored stool with jaundice suggests cholestasis — document and communicate |
| Total vs fractions | Never chart “bilirubin high” without naming direct and indirect values |
| Light protection | Follow lab policy for light-sensitive transport — pre-analytic error can mislead trends |
| Gilbert pattern | Mild indirect rise in well patients may be benign — still notify prescriber per protocol |
| Gallstone context | Direct rise with pain and fever may need urgent imaging — do not delay notification for ultrasound timing alone |
Bilirubin Fractionation in Hepatic Workup Workflow
Diagnostic safety badge: Critical-result test — prompt review and escalation may be required when institution-defined thresholds or acute cholestatic signs are present.
Check-before-test protocol
- Identity + correct LFT/fractionation order + fasting status
- Symptom baseline: jaundice, urine and stool color, pruritus, pain
- Light-protected tube, label, and laboratory transport
- Prior bilirubin fraction trend reviewed
- Plan for result review with ALT, ALP, GGT, and urine bilirubin
Critical teach-back questions
- “Can you tell me why we are checking direct and indirect bilirubin today?”
- “Which symptoms — yellow skin or eyes, dark urine, pale stool, fever, or severe belly pain — should you report right away?”
- “Can you tell me whether fasting is required for this blood work today?”
Care coordination: primary prescriber, laboratory, phlebotomy, medical imaging, hepatology, gastroenterology, hematology, and rapid response per institutional protocol when acute liver or biliary disease is suspected.
Bilirubin Fractionation Quick Clinical Checklist
- Did I review direct and indirect fractions — not total bilirubin alone?
- What did urine bilirubin and stool color show at the bedside?
- How do ALT, ALP, and GGT support the same clinical story?
- What did prior bilirubin fractions look like — stable, rising, or falling?
- Who must be notified now if direct bilirubin is critical or the patient is deteriorating?
Why Bilirubin Fractionation is Ordered
Bilirubin fractionation is ordered when clinicians need to evaluate jaundice, monitor liver or biliary disease, or distinguish cholestatic from hemolytic or conjugation patterns.
| Clinical Indication | What the Test Answers | Nursing Rationale |
|---|---|---|
| Visible jaundice or suspected hyperbilirubinemia | Is bilirubin elevated, and which fraction predominates? | Direct elevation supports cholestasis or obstruction workup; indirect elevation prompts hemolysis or conjugation assessment per clinical context. |
| Abnormal liver function panel follow-up | Does fractionation clarify a cholestatic vs hepatocellular pattern? | Pairing bilirubin fractions with ALT, ALP, and GGT helps guide imaging and specialist referral per hepatology references. |
| Suspected hemolysis with unconjugated hyperbilirubinemia | Is indirect bilirubin disproportionately elevated with compatible symptoms? | Indirect predominance with anemia symptoms or hemolysis risk supports expanded hematology workup as ordered. |
| Monitoring known cholestatic or hepatic disease | Is direct bilirubin improving, stable, or worsening on therapy? | Serial fraction trends support treatment response and escalation when conjugated bilirubin rises despite intervention. |
Contraindications and Precautions
Venous blood draw for bilirubin fractionation has few true contraindications. Nursing focus is on safe phlebotomy, light-protected specimen handling, and when not to dismiss clinically significant fraction patterns.
- Rapidly rising direct bilirubin with fever, RUQ pain, jaundice, or hypotension — possible cholangitis or biliary obstruction; escalate per facility policy
- Marked indirect bilirubin rise with hemolysis symptoms, dropping hemoglobin, or dark urine without bilirubin on dipstick — coordinate urgent hematology evaluation
- Conjugated hyperbilirubinemia with encephalopathy, coagulopathy, or acute deterioration — notify prescriber and rapid response per protocol
- Light exposure may degrade bilirubin — follow laboratory transport and storage guidance
- Hemolyzed specimens may affect chemistry quality — recollect if sample is compromised
- Do not equate total bilirubin alone with clinical urgency — always review direct vs indirect fractions and urine bilirubin status
- Rising direct bilirubin with jaundice, dark urine (bilirubin positive), pruritus, or pale stool
- Indirect bilirubin rising with hemolysis signs, anemia, or splenomegaly concern
- Total bilirubin rising on serial testing with fever, abdominal pain, or altered mental status
Patient Preparation
Preparation depends on whether bilirubin is drawn alone or with fasting panels. Confirm order components and specimen handling with the laboratory when in doubt.
Pre-test checksReview medicines that affect liver or biliary function, hemolysis risk, or conjugation (e.g., valproate, rifampin, certain antibiotics, herbal products, alcohol). Standard clinical references advise patients not to stop medicines before testing unless the provider instructs them to. Nurses communicate suspected drug-related jaundice when direct bilirubin rises on therapy.
Performance — nursing procedure guide
This page is a Tests & Diagnostics guide for Bilirubin Fractionation. It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).
Step-by-step technique, supplies, infection prevention, and immediate post-procedure monitoring for this test are covered in:
Use the Patient preparation, Results and interpretation, and Nursing responsibilities sections on this page for order verification, pre-analytic checks, result follow-up, critical-value escalation, and documentation.
Result follow-up at a glance
Nursing workflow on this page — from order to safe action on results:
Results and Interpretation
Bilirubin is reported in mg/dL or µmol/L using the reporting laboratory’s reference interval. Compare total, direct, and indirect (calculated) values to the printed range and to the patient’s prior results.
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
| Result | Range / Finding | Clinical Meaning | Nursing Action |
|---|---|---|---|
| Within reference interval | Institution- and laboratory-specific — Turnaround and screening rules vary by institution; follow local institutional policy as one universal numeric range | No current biochemical evidence of significant hyperbilirubinemia on this assay | Continue routine monitoring per indication; do not dismiss jaundice if clinical findings persist |
| Borderline / near reference limit | Just above upper reference limit or mildly elevated vs prior baseline | May reflect early cholestasis, hemolysis, or Gilbert syndrome pattern — correlate direct vs indirect fractions, urine bilirubin, and symptoms | Ensure trend testing and prescriber review; document urine and stool color |
| High / above reference interval | Above institutional upper reference limit or rising serial values | Hyperbilirubinemia — direct predominance suggests cholestasis/obstruction; indirect predominance suggests hemolysis or impaired conjugation per standard clinical references | Notify prescriber; review full liver panel; monitor symptoms; arrange imaging or hematology workup as ordered |
| Low / below reference interval | Below reference interval (uncommon for bilirubin) | Low bilirubin is rarely clinically significant — interpret with full panel and context | Do not assume pathology; correlate with symptoms and companion liver tests |
Critical Results and Escalation
Universal numeric critical bilirubin thresholds are Turnaround and screening rules vary by institution; follow local institutional policy. Many institutions define chemistry critical values locally. Escalate when direct bilirubin is markedly elevated, rising rapidly, or associated with sepsis signs, acute abdominal pain, or liver failure.
| Critical Finding | Threshold / Value | Immediate Action |
|---|---|---|
| Marked direct (conjugated) bilirubin elevation with biliary symptoms | Institution-defined critical value and/or cholestatic pattern with jaundice and pain | Critical-value notification and prescriber escalation per policy; coordinate urgent hepatobiliary imaging as ordered |
| Rapidly rising indirect bilirubin with hemolysis concern | Significant upward trend with anemia symptoms or falling hemoglobin | Notify prescriber; coordinate CBC, reticulocyte count, and hematology review per orders |
| Hyperbilirubinemia with encephalopathy or coagulopathy | Rising bilirubin with altered mental status or prolonged INR | Escalate according to facility policy; coordinate urgent medical or hepatology review |
Escalate according to facility policy and the patient’s clinical condition when bilirubin fractions conflict with stability, when critical values are reported, or when new jaundice, bleeding, encephalopathy, or hypotension develops.
Factors Affecting Results
Bilirubin fraction interpretation depends on laboratory method, light exposure, specimen quality, hemolysis, and patient factors.
- Mild total bilirubin elevation from fasting or Gilbert syndrome without urgent pathology
- Artifact from hemolyzed or light-exposed specimen leading to unreliable fractions
- Assuming all jaundice is “liver failure” without reviewing direct vs indirect pattern
- Normal total bilirubin while direct fraction is rising — trend fractions, not total alone
- Ignoring positive urine bilirubin when serum total appears only mildly elevated
- Checking total bilirubin without direct/indirect fractionation when cholestasis is suspected
- Light exposure, hemolysis, delayed processing, or wrong specimen type
- Fasting status, hemolysis, medicines, and alcohol use
- Age, hemolysis risk, biliary disease, and postoperative recovery
Bilirubin fractionation identifies hyperbilirubinemia type but does not localize obstruction or diagnose specific disease without imaging, history, and companion tests (standard clinical references; standard clinical references liver function tests). Urine bilirubin supports conjugated patterns but does not replace serum fractionation.
Nursing Responsibilities
Nursing care spans safe phlebotomy, urine and stool assessment, trend communication, and patient teaching about jaundice red flags.
Before the TestDocumentation
Clear documentation supports continuity when bilirubin fractions trend during jaundice workup or cholestasis monitoring.
“Total bilirubin 8.2 mg/dL (H), direct 5.8 mg/dL (H), indirect 2.4 mg/dL at 0742 on fasting LFT panel; prior direct 2.1 mg/dL one week ago. Urine dipstick bilirubin positive; patient reports pale stool and RUQ tenderness. ALP and GGT elevated. Dr. Patel notified per policy; abdominal ultrasound pending. Patient taught to report fever or worsening pain.”
- Indication, fasting status, and tests collected on same specimen
- Total, direct, and indirect values with laboratory reference intervals and trends
- Urine bilirubin, stool color, companion LFTs, and pertinent symptoms
- Medicines and alcohol use reviewed and communicated
- Critical-value read-back and prescriber notification
- Patient teaching and pending imaging or repeat-test plan
Patient and Family Education
Use plain language while emphasizing that bilirubin fractions help explain jaundice but do not diagnose a single condition alone.
Bilirubin Fractionation NCLEX practice questions
Practice NCLEX-style clinical judgment focused on Bilirubin Fractionation safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.
Select a tab to view orders, results, assessment, and nursing note details for this case.
- Order: Liver panel with total and direct bilirubin fractionation — jaundice workup
- Indication: Progressive jaundice, dark urine, and RUQ discomfort; evaluate cholestasis
- Timing: Fasting LFT panel collected 0730; urine dipstick bilirubin positive at bedside
- Related orders: LFT with bilirubin fractionation; abdominal ultrasound ordered; CBC pending
- Result: Total bilirubin 8.2 mg/dL (H), direct 5.8 mg/dL (H), indirect ~2.4 mg/dL; ALP and GGT elevated; prior direct 2.1 mg/dL one week ago
- Trend / prior value: Direct bilirubin rising over one week with cholestatic enzyme pattern
- Pending tests: Abdominal ultrasound not yet completed; prescriber not yet notified of full panel
- Vital signs: T 38.3°C, HR 108/min, BP 92/58 mmHg, RR 20/min, SpO₂ 96% on room air
- Symptoms: Scleral icterus, tea-colored urine, pale stool, RUQ tenderness, fatigue
- Focused assessment: Alert but uncomfortable; skin jaundiced; no reported hematemesis
- Preparation notes: Fasting confirmed; patient took prescribed statin; unsure about recent acetaminophen use
- Collection events: Specimen labeled correctly; transported in light-protective pouch per lab policy
- Teaching gaps / safety concerns: Rising direct bilirubin with positive urine bilirubin, fever, hypotension, and incomplete prescriber notification
Answer key & rationale
Frequently Asked Questions
FAQ
What is the difference between direct and indirect bilirubin?
Direct (conjugated) bilirubin has been processed by the liver for excretion. Indirect (unconjugated) bilirubin has not. Many laboratories report total and direct bilirubin and calculate indirect as total minus direct.
Why is urine bilirubin important in jaundice workups?
Positive urine bilirubin indicates conjugated hyperbilirubinemia because unconjugated bilirubin is not water-soluble and does not appear in urine. Nurses correlate urine findings with serum fractions guidance.
Does the patient need to fast before bilirubin fractionation?
Fasting is not always required for bilirubin alone. When bilirubin is ordered with other fasting chemistry tests, Standard clinical references advise following provider instructions — nurses should confirm the specific order.
What does elevated direct bilirubin suggest?
Elevated direct bilirubin suggests cholestasis or impaired bilirubin excretion — causes may include biliary obstruction, hepatitis, or medication effects. It does not confirm a specific diagnosis without imaging and clinical correlation.
What does elevated indirect bilirubin suggest?
Elevated indirect bilirubin may occur with hemolysis, ineffective erythropoiesis, or impaired conjugation (e.g., Gilbert syndrome). standard clinical references unconjugated hyperbilirubinemia content emphasizes interpreting with hemolysis markers and history.
When should nurses escalate bilirubin fractionation results?
Escalate when institution-defined critical values are reported, when direct bilirubin rises rapidly, when jaundice pairs with fever, pain, or hypotension, or when results conflict with clinical stability — according to facility policy.
Can total bilirubin alone explain the clinical picture?
No. Total bilirubin combines direct and indirect fractions. ACG/AASLD abnormal liver chemistries guidance supports evaluating cholestatic patterns with fractionation and companion enzymes rather than relying on total bilirubin alone.
References
References
-
U.S. National Library of Medicine. Bilirubin Blood Test. MedlinePlus.https://medlineplus.gov/lab-tests/bilirubin-blood-test/
-
Lala V; Zubair M; Minter DA. Liver Function Tests. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026.https://www.ncbi.nlm.nih.gov/books/NBK482489/
-
Mitchell A; Hsu C. Unconjugated Hyperbilirubinemia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.https://www.ncbi.nlm.nih.gov/books/NBK549796/
-
Kwo PY; Cohen SM; Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18-35.https://doi.org/10.1038/ajg.2016.517
-
American Association for the Study of Liver Diseases. AASLD Practice Guidance on Evaluation of Abnormal Liver Chemistries.https://www.aasld.org/practice-guidelines
-
U.S. National Library of Medicine. Liver Function Tests. MedlinePlus.https://medlineplus.gov/lab-tests/liver-function-tests/
-
American College of Gastroenterology. Evaluation of Abnormal Liver Chemistries. ACG Clinical Guideline resource.https://gi.org/guideline/evaluation-of-abnormal-liver-chemistries/
-
U.S. National Library of Medicine. Bilirubin. MedlinePlus Medical Encyclopedia.https://medlineplus.gov/ency/article/003479.htm
Editorial Standards & Medical Review
About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.
Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Bilirubin Fractionation.
Policies: Medical Review Process · Editorial Policy · Correction Policy